Typhoid Fever Vaccines Market Trends by Rising Government Initiatives for Disease Control
The typhoid fever vaccines market comprises vaccines that help prevent typhoid, a serious bacterial infection caused by Salmonella Typhi. These vaccines work by triggering the body's natural defenses against the infection. There are two main types of typhoid vaccines available - live, attenuated oral vaccines that provide long-term protection with one dose but can cause side effects; and injectable vaccines that offer shorter-term protection but are generally better tolerated. Widespread vaccination programs by various governments aim to curb the rising burden of the infectious disease in developing nations.
The Global Typhoid Fever Vaccines Market is estimated to be valued at US$ 454.2 Bn in 2024 and is expected to exhibit a CAGR of 14.% over the forecast period 2024 to 2031.
Typhoid Fever Vaccines Market
Key Takeaways
Key players operating in the typhoid fever vaccines are Linde Plc, Air
Liquide, Engie, Uniper Se, Air Products Inc, Clean Hydrogen System, Cummins
Inc., Toshiba Energy Systems & Solutions Corporation, Nel Asa, and Sgh2
Energy. Growing awareness about typhoid prevention through vaccination and
continuous development of improved vaccines are fueling the demand in the
market. Major companies are expanding their presence globally especially in
Asian and African countries to tap the business opportunities.
Market key trends
One of the key trends in the Typhoid
Fever Vaccines Market Share is the rising focus of governments and
non-profit organizations as well as international bodies like WHO and UNICEF on
immunization programs in developing nations. Countries like India where typhoid
is highly endemic are witnessing extensive vaccination drives to control the
disease and its spread. This is expected to significantly drive the uptake of
typhoid fever vaccines during the forecast period.
Porter’s
Analysis
Threat of new entrants: Vaccine development requires high R&D investments
and clinical trials making entry difficult for new players.
Bargaining power of buyers: Buyers have moderate bargaining
power due to availability of substitutes and presence of established players.
Bargaining power of suppliers: Suppliers have moderate
bargaining power due to availability of substitutes and differentiation in
products.
Threat of new substitutes: Threat of substitutes is moderate
as vaccine development requires huge investments and drugs have their own side
effects.
Competitive rivalry: Intense competition exists among
existing players to gain higher market share.
Geographical regions
North America accounts for the largest share of the typhoid fever vaccines
market currently. This is attributed to factors such as rise in awareness
regarding immunization, significant per capita healthcare expenditure, and
technologically advanced healthcare facilities in the region. Asia Pacific
exhibits the fastest growth and is expected to grow at fastest CAGR over the
forecast period. Increasing prevalence of typhoid fever disease, growing
disposable incomes, improving healthcare infrastructure are driving the market
in the Asia Pacific region.
Get more insights on Typhoid
Fever Vaccines Market
About
Author:
Money
Singh is a seasoned
content writer with over four years of experience in the market research
sector. Her expertise spans various industries, including food and beverages, biotechnology,
chemical and materials, defense and aerospace, consumer goods, etc.
Comments
Post a Comment